Ctrl Worx Watch List › Company

Adaptin Bio, Inc. (APTN): material weakness open 1,125 days

By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.

Adaptin Bio, Inc. reported ineffective internal control over financial reporting because of a material weakness in 3 filings since Apr 1, 2024. It stated one or more material weaknesses in 9 more SEC filings that gave no conclusion on whether that control is effective. The latest was its 10-Q for the period ended Jun 30, 2026.

Checked against SEC EDGAR: Oct 29, 2026 · Entry #12387

Causes the company named

Accounting expertise and resources · 9Segregation of duties · 9Complex or non-routine accounting · 6Tax · 6Entity-level and governance · 5Financial close and reporting · 2

What the latest filing says

Based on this evaluation, and as a result of the material weaknesses described below, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Form 10-Q. Material Weaknesses in Internal Control over Financial Reporting A material weakness, as defined in the standards established by the Sarbanes-Oxley Act, is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or unaudited interim condensed consolidated financial statements will not be prevented or detected on a timely basis. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. The following material weaknesses in our internal control over financial reporting were present as of December 31, 2025 and continued to exist a [...]

From the controls section of the 10-Q filed Aug 13, 2026. Read the full filing on SEC EDGAR.

Company response: Adaptin Bio, Inc. can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.

Filings

Follow APTN for free

Get an email when Adaptin Bio, Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.

Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Adaptin Bio, Inc. or the SEC. Not investment advice. Why you can rely on the Watch List.